后COVID-19疫苗接种 (或长时间的疫苗接种) 综合征:假定表现,病理生理学和治疗选择
Shin Jie Yong1, Tiff-Annie Kenny2,3, Alice Halim4
1School of Medical and Life Sciences, Sunway University, Sunway City, Malaysia.
Reviews in medical virology
|September 13, 2025
概括
后COVID-19疫苗接种综合征 (PCVS) 是疫苗接种后出现的长期COVID状况. 需要进行研究来了解PCVS的流行率,风险因素和治疗方法.
科学领域:
- 免疫学 免疫学 免疫学
- 神经学 神经学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 在全球推出期间,COVID-19疫苗的安全性至关重要.
- 人们担心疫苗接种后长期出现的类似COVID的综合征,称为COVID-19疫苗接种后综合征 (PCVS).
研究的目的:
- 审查PCVS的表现,病理生理学和潜在的治疗方法.
- 从病例报告和观察性研究中综合PCVS的当前证据.
主要方法:
- 现有文献的叙述性审查.
- 对病例报告,病例系列和PCVS的观察性研究进行分析.
主要成果:
- 疫苗接种后几天到几周,PCVS会出现,症状持续数月到数年.
- PCVS可以呈现为POTS,SFN,ME/CFS,或心肌炎,VITT或ITP的后续.
- 长期COVID (疲劳,脑雾) 与PCVS症状重叠,但可能包括更多的麻醉和更少的呼吸障碍.
结论:
- PCVS病理生理学可能涉及疫苗尖端蛋白和免疫反应.
- 目前的治疗方法基于有限的病例数据,需要进一步研究.
- 人们对PCVS的了解很少,因此需要对其患病率,预后,危险因素和治疗方法进行更多研究.
相关概念视频
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
363
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
363
COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
Myocarditis III: Medical Management
175
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
175
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Myocarditis IV: Nursing Management
209
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
209
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K

